4 Largecap Stocks For 1 Year to Watch for Future Multibagger Potential: Divi's Labs, BHEL, BSE and Laurus Labs

Stocks for 1 year to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Divi's Labs, BHEL, BSE and Laurus Labs meet that test, with market caps from Rs 1.09 lakh crore to Rs 2.40 lakh crore and Divi's Labs offering the largest market cap at Rs 2,39,982 crore. Each of these shares gained more than 30 per cent over the past year, and net profit grew by more than 15 per cent in FY26 and by more than 60 per cent in the latest quarter.

This list covers shares with a past-year gain above 30 per cent, FY26 profit growth above 15 per cent, latest-quarter profit growth above 60 per cent and market capitalisation above Rs 1,00,000 crore. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks for 1 year usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Stocks For 1 Year and Why Do They Attract Multibagger Interest?

Stocks for 1 year are shares where price momentum and earnings momentum are moving together. The four here cover power equipment, pharmaceuticals and a stock exchange.

A one-year view favours companies whose results are improving right now. For stocks for 1 year, recent quarterly growth supports the share price trend. With stocks for 1 year, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for stocks for 1 year are complete. Read each company's latest results and exchange filings before acting on stocks for 1 year.

Stocks For 1 Year at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 20 October 2026. BSE combines the lowest PE of the group, 49.55, with the highest return on equity, 37.42%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Divi's Laboratories	9,087	2,39,982	82.05	36.42	15.32%	0.00	5,647.50 to 9,740.00
Bharat Heavy Electricals	427.35	1,51,365	52.56	45.89	10.76%	0.23	229.54 to 464.00
BSE Ltd	3,336	1,39,823	49.55	42.42	37.42%	0.00	2,326.10 to 4,446.80
Laurus Labs	2,069	1,09,143	100.10	36.42	16.77%	0.48	864.70 to 2,085.90

Divi's Labs: Debt-to-Equity of 0.00

Divi's Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026. The stock trades at a PE of 82.05 against an industry PE of 36.42, with a return on equity of 15.32%.

BHEL: 37.73% Profit CAGR Since FY22

Bharat Heavy Electricals is a government-owned maker of power generation, transmission, industrial and transportation equipment. It reported FY26 revenue of Rs 34,589.83 crore, up 20.08% year on year, and net profit of Rs 1,600.26 crore, up 199.73%. Net profit has compounded at 37.73% a year since FY22, while revenue has grown 12.54% a year. Operating margin was 10.18% in FY26. The debt-to-equity ratio is 0.23.

The stock trades at a PE of 52.56 against an industry PE of 45.89. In the September 2026 quarter, revenue rose 24.28% to Rs 9,553.01 crore and net profit grew 118.98% to Rs 820.94 crore. The share price has gained 488.34% over five years and 86.13% over the past year. Domestic institutions raised their holding from 18.62% in September 2025 to 21.88% in September 2026.

BSE: 78.30% Profit CAGR Since FY22

BSE Ltd operates one of India's two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026. The stock trades at a PE of 49.55 against an industry PE of 42.42, with a return on equity of 37.42%.

Laurus Labs: Revenue Up 22.01% in FY26

Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.

The stock trades at a PE of 100.10 against an industry PE of 36.42, with a return on equity of 16.77%. In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026.

Stocks For 1 Year: Financial Comparison on Growth and Margins

The table compares scale and growth across these stocks for 1 year. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Divi's Labs	11,067	2,568	13.95%	5.09%	24.32%	42.82%
BHEL	34,589.83	1,600.26	20.08%	12.54%	24.28%	13.94%
BSE	5,148.10	2,475.30	59.07%	56.26%	63.41%	77.03%
Laurus Labs	6,867.85	889.85	22.01%	8.53%	28.83%	31.95%

Check the Univest Screener for live data on these stocks for 1 year

Institutional Holding in Divi's Labs, BHEL, BSE and Laurus Labs

Institutional holding shows who is backing these stocks for 1 year alongside the promoter. The table uses the latest reported quarter for each. BSE has the deepest institutional backing, with FII and DII together holding 45.47% as of June 2026. Domestic institutions increased their holding over the past year in BHEL (from 18.62% to 21.88%), BSE (from 13.51% to 24.15%) and Laurus Labs (from 11.94% to 13.74%).

Stock	Promoter	FII	DII	Public	Quarter
Divi's Labs	51.88%	20.38%	19.17%	8.58%	September 2026
BHEL	58.17%	9.94%	21.88%	10.02%	September 2026
BSE	Nil	21.32%	24.15%	54.53%	June 2026
Laurus Labs	27.47%	28.00%	13.74%	30.78%	June 2026

Risks to Weigh in Stocks For 1 Year

Being careful with stocks for 1 year means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Stocks For 1 Year

Picking from stocks for 1 year comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (36.42 to 45.89) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Divi's Labs, BHEL, BSE and Laurus Labs live prices.

Conclusion

Among stocks for 1 year, Divi's Labs stands out for the largest market cap at Rs 2,39,982 crore, BHEL for 20.08% revenue growth in FY26, BSE for the highest return on equity at 37.42% and Laurus Labs for the strongest latest-quarter profit growth at 124.73%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks for 1 year should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Stocks For 1 Year to Watch

Which are the best stocks for 1 year to watch for multibagger potential?

Ans. Divi's Labs, BHEL, BSE and Laurus Labs are the 4 names this list highlights, with market caps of Rs 2,39,982 crore, Rs 1,51,365 crore, Rs 1,39,823 crore and Rs 1,09,143 crore respectively. Divi's Labs is notable for the largest market cap at Rs 2,39,982 crore. BHEL stands out for 20.08% revenue growth in FY26. BSE offers the highest return on equity at 37.42%. Laurus Labs brings the strongest latest-quarter profit growth at 124.73%. These are watchlist names for stocks for 1 year, not recommendations, so match each one to your own risk profile and time horizon.

Is BSE a good stock for long-term investors?

Ans. BSE has a return on equity of 37.42%, a PE of 49.55 against an industry PE of 42.42 and a market cap of Rs 1,39,823 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in stocks for 1 year depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can BHEL become a multibagger from here?

Ans. BHEL has already gained 488.34% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks for 1 year requires earnings to keep growing faster than the market for several years. Net profit has compounded at 37.73% a year since FY22, and FY26 revenue rose 20.08%. At a PE of 52.56 against an industry PE of 45.89, valuation should be checked against that growth before investing.

What is the market cap of Divi's Labs, BHEL, BSE and Laurus Labs?

Ans. As of 20 October 2026, Divi's Labs has a market cap of Rs 2,39,982 crore, BHEL has a market cap of Rs 1,51,365 crore, BSE has a market cap of Rs 1,39,823 crore and Laurus Labs has a market cap of Rs 1,09,143 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks for 1 year.

What are the risks of investing in stocks for 1 year?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Laurus Labs trading at a PE of 100.10?

Ans. Laurus Labs' PE of 100.10 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in stocks for 1 year who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Divi's Labs, BHEL, BSE and Laurus Labs?

Ans. As of the latest reported quarter, FII and DII together hold 39.55% of Divi's Labs (20.38% and 19.17%), 31.82% of BHEL (9.94% and 21.88%), 45.47% of BSE (21.32% and 24.15%) and 41.74% of Laurus Labs (28.00% and 13.74%). Rising institutional holding is a useful signal in stocks for 1 year, though it should be read with earnings trends rather than on its own.